Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-88.47	10.53	91.39
Graham Fair Price	85.52	6779.04	3654.08
PEG	-82.99	< 0.005	0.03
Price/Book	-5.73	0.63	0.67
Price/Cash Flow	230.35	10.63	-3.22
Prices/Earnings	-67.66	2.20	-6.79
Price/Sales	-26.55	1.15	1.56
Price/FCF	230.35	10.63	-3.22
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	33.00	0.37	0.28
Operating Margin	3681.86	0.19	< 0.005
ROA	188.18	0.03	< 0.005
ROE	-0.02	0.07	191.52
ROIC	< 0.005	0.04	2359.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.04	0.15	-76.03
Dividends QOQ	-0.98	-0.95	2.90
EBIT QOQ	-1.11	53.76	4736.04
EPS QOQ	-2.19	4.17	90.08
FCF QOQ	-0.47	1.31	179.83
Revenue QOQ	0.18	0.40	116.62
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.49	0.48	-2.40
Quick Ratio	0.24	0.28	18.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	4899.81	5323.97	8.66
Cash	1264.53	1702.00	34.60
Capex	-167.13	77.46	-53.65
Free Cash Flow	-1022.56	317.06	-68.99
Revenue	2102.76	2932.55	39.46
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.17	1.21	2.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.66	5.25	-88.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating